BCMA Re-Emergence As a Prognostic Indicator of Clinical Relapse after Chimeric Antigen Receptor T-Cell Therapy (CART) in Multiple Myeloma

被引：0
|
作者：
Rashid, Aliya [1 ,2 ,3 ]
Wesson, William [2 ,4 ,5 ]
Lutfi, Forat [1 ,5 ]
Mushtaq, Muhammad Umair [5 ]
McGuirk, Joseph P. [5 ,6 ]
Abdallah, Al-Ola
Cui, Wei [7 ]
Ahmed, Nausheen [5 ]
机构：
[1] US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USA
[2] Univ Kansas, Div Hematol Malignancies & Cellular Therapeut, Ctr Canc, Kansas City, MO USA
[3] Univ Kansas, Med Ctr, Internal Med, Kansas City, KS USA
[4] Univ Kansas, Sch Med, Kansas City, KS USA
[5] Univ Kansas, Div Hematol Malignancies & Cellular Therapeut, Med Ctr, Kansas City, KS USA
[6] Univ Kansas, Med Ctr, Westwood, KS USA
[7] Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-182126
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Chimeric antigen receptor T cell therapy for multiple myeloma
    Hasegawa, Kana
    Hosen, Naoki
    INFLAMMATION AND REGENERATION, 2019, 39 (1)
  • [22] Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma
    Costa, Bruno Almeida
    Flynn, Jessica
    Nishimura, Noriko
    Devlin, Sean M.
    Farzana, Tasmin
    Rajeeve, Sridevi
    Chung, David J.
    Landau, Heather J.
    Lahoud, Oscar B.
    Scordo, Michael
    Shah, Gunjan L.
    Hassoun, Hani
    Maclachlan, Kylee
    Hultcrantz, Malin
    Korde, Neha
    Lesokhin, Alexander M.
    Shah, Urvi A.
    Tan, Carlyn R.
    Giralt, Sergio A.
    Usmani, Saad Z.
    Nath, Karthik
    Mailankody, Sham
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [23] CARTITUDE-2: Efficacy and Safety of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T-Cell Therapy, in Patients with Multiple Myeloma and Early Relapse after Initial Therapy
    Van de Donk, Niels W. C. J.
    Delforge, Michel
    Agha, Mounzer
    Cohen, Adam D.
    Cohen, Yael C.
    Hillengass, Jens
    Anguille, Sebastien
    Kerre, Tessa
    Roeloffzen, Wilfried
    Schecter, Jordan M.
    De Braganca, Kevin C.
    Varsos, Helen
    Wang, Liwei
    Vogel, Martin
    Zudaire, Enrique
    Corsale, Christina
    Akram, Muhammad
    Geng, Dong
    Nesheiwat, Tonia
    Pacaud, Lida
    Sonneveld, Pieter
    Zweegman, Sonja
    BLOOD, 2021, 138
  • [24] Comprehensive meta-analysis of anti-BCMA chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma
    Zhang, Lina
    Shen, Xuxing
    Yu, Wenjun
    Li, Jing
    Zhang, Jue
    Zhang, Run
    Li, Jianyong
    Chen, Lijuan
    ANNALS OF MEDICINE, 2021, 53 (01) : 1547 - 1559
  • [25] Cardiovascular Effects of Chimeric Antigen Receptor T-Cell (CART Cell) Therapy in Adults
    Lefebvre, Benedicte
    Kang, Yu
    Frey, Noelle
    Carver, Joseph R.
    Scherrer-Crosbie, Marielle
    CIRCULATION, 2019, 140
  • [26] A Review of Chimeric Antigen Receptor T-Cell Therapy for Myeloma and Lymphoma
    Atrash, Shebli
    Moyo, Tamara K.
    ONCOTARGETS AND THERAPY, 2021, 14 : 2185 - 2201
  • [27] Clinical Predictors of Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy
    Rubin, Daniel B.
    Al Jarrah, Ali
    Li, Karen
    LaRose, Sarah
    Monk, Andrew D.
    Ali, Ali Basil
    Spendley, Lauren N.
    Nikiforow, Sarah
    Jacobson, Caron
    Vaitkevicius, Henrikas
    JAMA NEUROLOGY, 2020, 77 (12) : 1536 - 1542
  • [28] Nursing Care Throughout the Chimeric Antigen Receptor T-Cell Therapy Process for Multiple Myeloma
    Steinbach, Mary
    Zitella, Laura J.
    Florendo, Erika
    Lee, Erin
    Riccobono, Carrie
    DiFilippo, Heather
    Aronson, Elizabeth
    SEMINARS IN ONCOLOGY NURSING, 2023, 39 (06)
  • [29] Management of bone disease with concurrent chimeric antigen receptor T-cell therapy for multiple myeloma
    Kuruvilla, Davis
    Huynh, Thien
    Nester, Matthew
    Chose, Chloe
    Zervoudakis, Guston
    Letson, G. Douglas
    Joyce, David M.
    Binitie, Odion T.
    Figura, Nicholas B.
    Costello, James R.
    Freeman, Ciara L.
    Lazarides, Alexander L.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 201
  • [30] Chimeric Antigen Receptor T-Cell and Bispecific Antibody Therapy in Multiple Myeloma: Moving Into the Future
    Holstein, Sarah A.
    Grant, Shakira J.
    Wildes, Tanya M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (27) : 4416 - +
12345